Genedata
Private Company
Total funding raised: $45M
Overview
Genedata is a long-established, private enterprise software leader specializing in digital solutions for the biopharma industry. Its core offering, the Genedata Biopharma Platform, provides a unified data model, workflow automation, and embedded AI to streamline operations from discovery through development and manufacturing. The company is trusted by major pharmaceutical firms, leverages a deep understanding of scientific workflows, and operates on a platform business model with a proven, revenue-generating track record. Its strategic focus is on becoming an essential digital infrastructure partner as the industry accelerates its adoption of automation and AI.
Technology Platform
The Genedata Biopharma Platform: a unified enterprise software suite with a biologics-native data model, workflow automation, and embedded AI for end-to-end biopharmaceutical R&D and manufacturing. Comprises seven systems (Screener, Biologics, Bioprocess, Chromatics, Expressionist, Selector, Profiler) supporting all major therapeutic modalities.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Genedata competes in the enterprise software space for biopharma R&D. Key competitors include Dotmatics (broad R&D informatics), Benchling (cloud-native R&D platform primarily for biotech), and Veeva (strong in clinical and commercial, expanding into R&D). Its primary differentiators are its deep biologics specialization, unified end-to-end platform covering discovery through manufacturing, and 25+ years of domain expertise embedded in its software.